Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 172   

Articles published

GSK 1,565.50 +19.50 (1.26%)
price chart
Should You Follow Neil Woodford And Buy GlaxoSmithKline plc, AstraZeneca ...
Neil Woodford has been an investor in the pharmaceuticals industry for most of his long career. In a recent blog, the ace fund manager wrote: "The pharmaceuticals sector is no longer as cheap as it was but it still looks very attractive in my view ...
GlaxoSmithKline plc (ADR) And NewLink Genetics Corp, Ebola Vaccines Clear ...
The US National Institutes of Health (NIH) said that two experimental Ebola vaccines, one from GlaxoSmithKline plc (ADR) (NYSE:GSK) and another from NewLink Genetics Corp (NASDAQ:NLNK), �appear to be safe,� as per the initial data review of mid-stage ...
GlaxoSmithKline plc Receives "Underperform" Rating from BNP Paribas (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its �underperform� rating reiterated by analysts at BNP Paribas in a research report issued to clients and investors on Wednesday.
Shore Capital Reaffirms Buy Rating for GlaxoSmithKline plc (GSK)  The Legacy
Is Hikma Pharmaceuticals Plc Now A Better Buy Than GlaxoSmithKline plc?
In fact, GlaxoSmithKline has struggled to an extent with this problem. Evidence of this can be seen in its disappointing performance during the same period, with its bottom line growing by around 8% per annum in the last five years.
GlaxoSmithKline plc's Overweight Rating Reiterated at Barclays (GSK)  Dakota Financial News
GlaxoSmithKline plc Stock Rating Reaffirmed by Shore Capital (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK)'s stock had its �buy� rating reiterated by investment analysts at Shore Capital in a note issued to investors on Friday.
GlaxoSmithKline plc's "Hold" Rating Reaffirmed at Kepler ...  Dakota Financial News
GlaxoSmithKline plc Rating Reiterated by Shore Capital (GSK)  WKRB News
3-Point Checklist: Should You Buy GlaxoSmithKline plc Or AstraZeneca plc?
GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) recently completed a complex multi-billion dollar asset swap deal with Swiss firm Novartis, which I believe will help to kick-start Glaxo's earnings growth and maintain the firm's enviable cash generation and ...
Will You Get Your Share Of GlaxoSmithKline plc's �4bn Special Dividend?
Income favourite GlaxoSmithKline (LSE: GSK) has finalised its impressively ambitious three-part deal with Swiss giant Novatis, and thus its shareholders can now look forward to a �4 billion cash return.
GlaxoSmithKline plc's Buy Rating Reiterated at Shore Capital (GSK)
Shore Capital restated their buy rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a report released on Friday. Shore Capital has also taken action a number of other healthcare stocks recently.
GlaxoSmithKline plc's Buy Rating Reiterated at Beaufort Securities (GSK)  WKRB News
Critical inspection of GlaxoSmithKline plc (ADR) (NYSE:GSK) by FDA ...
This respiratory drug Breo, by GlaxoSmithKline plc (ADR) (NYSE:GSK) has been critically examined by FDA consultants to check its security,while treatment of asthma, especially its convenience for children.
GlaxoSmithKline plc (ADR) Asthma Drug Wins Green Signal From FDA Panel ...  Bidness ETC
GSK and Theravance Announce Outcome of US FDA Advisory Committee on ...  CNNMoney
GlaxoSmithKline plc (ADR) Lays Off 180 More Workers In North Carolina
British pharmaceutical giant GlaxoSmithKline Plc (ADR) (NYSE:GSK) announced Monday another round of layoffs at its Research Triangle Park Campus in North Carolina.